Hoyoung Huh, M.D., Ph.D. has served as a member of Eidos’ board of directors since March 2016. He is the founder of pH Pharma and Healthcare & Humanity Foundation. He currently also serves as the chairman of the board of directors of Geron Corporation and CytomX Therapeutics. He is a member of the board of directors of Rezolute. Previously, Dr. Huh was the chief executive officer of BiPar Sciences, the chairman of the board of directors of Epizyme, a member of the board of directors of Facet Biotech, Nektar Therapeutics, Addex Therapeutics and EOS, S.p.A (Milano, Italy). Earlier in his career, Dr. Huh was a partner at McKinsey & Company. Dr. Huh holds A.B. in Biochemistry from Dartmouth College, and his M.D./Ph.D. in Cell Biology and Genetics from Cornell University Medical College.